Abstract:Plasminogen activator inhibitor 1 (PAI-1), a SERPIN inhibitor, is primarily known for its regulation of fibrinolysis. However, it is now known that this inhibitor functions and contributes to many (patho)physiological processes including inflammation, wound healing, cell adhesion, and tumor progression. This review discusses the past, present, and future roles of PAI-1, with a particular focus on the discovery of this inhibitor in the 1970s and subsequent characterization in health and disease. Throughout the past few decades diverse functions of this serpin have unraveled and it is now considered an important player in many disease processes. PAI-1 is expressed by numerous cell types, including megakaryocytes and platelets, adipocytes, endothelial cells, hepatocytes, and smooth muscle cells. In the circulation PAI-1 exists in two pools, within plasma itself and in platelet α-granules. Platelet PAI-1 is secreted following activation with retention of the inhibitor on the activated platelet membrane. Furthermore, these anucleate cells contain PAI-1 messenger ribonucleic acid to allow de novo synthesis. Outside of the traditional role of PAI-1 in fibrinolysis, this serpin has also been identified to play important roles in metabolic syndrome, obesity, diabetes, and most recently, acute respiratory distress syndrome, including coronavirus disease 2019 disease. This review highlights the complexity of PAI-1 and the requirement to ascertain a better understanding on how this complex serpin functions in (patho)physiological processes. G.B.M. researched, wrote, and edited the manuscript. N.J.M. conceived the idea and wrote/edited the manuscript. Article published online: 15 December 2022 © 2022. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Polymerization of Plasminogen Activator Inhibitor-1.

VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form

Probing nanosecond motions of plasminogen activator inhibitor-1 by time-resolved fluorescence anisotropy.

Functional Stability of Plasminogen Activator Inhibitor-1

Dimers Initiate and Propagate Serine Protease Inhibitor Polymerisation.

Modulation of Serpin Reaction Through Stabilization of Transient Intermediate by Ligands Bound to Α-Helix F

High-throughput amino acid-level characterization of the interactions of plasminogen activator inhibitor-1 with variably divergent proteases

Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition

Three Decades of Research on Plasminogen Activator Inhibitor-1: A Multifaceted Serpin

Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin

Purification of recombinant plasminogen activator inhibitor-1 in the active conformation by refolding from inclusion bodies

The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo

Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)

A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease

Long-range allostery mediates the regulation of plasminogen activator inhibitor-1 by cell adhesion factor vitronectin

Plasminogen Activator Inhibitor 1 (PAI-1) in Plasma: Its Role in Thrombotic Disease

Serpin Polymerization is Prevented by a Hydrogen Bond Network That is Centered on His-334 and Stabilized by Glycerol*

Orchestra of ligand-activated transcription factors in the molecular symphony of SERPINE 1 / PAI-1 gene regulation

How Small Peptides Block and Reverse Serpin Polymerisation

The Serpin Inhibitory Mechanism is Critically Dependent on the Length of the Reactive Center Loop

Proteoform-Resolved Profiling of Plasminogen Activation Reveals Novel Abundant Phosphorylation Site and Primary N-Terminal Cleavage Site